• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LIVANOVA CANADA CORP. PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LIVANOVA CANADA CORP. PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE Back to Search Results
Model Number PVS21
Device Problems Perivalvular Leak (1457); Inadequacy of Device Shape and/or Size (1583); Folded (2630)
Patient Problem Death (1802)
Event Date 11/26/2016
Event Type  Death  
Manufacturer Narrative
The valve was returned for analysis on mar 20, 2017.The gross examination has been completed on mar 21, 2017.
 
Event Description
The perceval s valve was implanted on (b)(6) 2016.A few hours after successful implantation, the valve developed a severe paravalvular leak because of folding/ lateral collapse of its ring.The valve was explanted and a new aortic valve was implanted.However, because of hemodynamic instability, the patient died in the operation room.
 
Event Description
Additional information was received on apr 6, 2017.: the patient had emergency replacement to replace the valve with a carpentier-edwards perimount magna ease bio-prosthesis carried 19 mm.It was stated it was also necessary to extend the small annulus.In the patient, apart from a calcified ascending aorta, there were no other known secondary diseases.
 
Manufacturer Narrative
The manufacturing and material records for the perceval heart valve and nitinol stent component, model #icv1208 , s/n # (b)(4) were pulled and reviewed by quality control at livanova (b)(4) corp.The results confirmed that this valve satisfied all material, visual, and performance standards required for a (model #icv1208) perceval heart valve at the time of manufacture and release.Visual inspection and p-np gauge dimensional analysis further confirmed that the valve was in line with the release specifications.X-ray analysis confirmed the absence of structural fracture in the valve stent.Simulation of the valve collapsing, deployment and ballooning in a silicon aortic root according with the indication included in the ifu (perceval s ¿ sutureless aortic heart valve ¿ instructions for use ¿ic0215001345 rev.H) revealed that it was not possible to replicate the reported folding event.Based on the performed analyses, it was concluded that the reported event cannot be explained by any factor intrinsic to the involved device.The physician report indicated that an aortic root enlargement was necessary to implant a 19 mm carpentier-edwards perimount magna ease bio-prosthesis following the perceval explant.This indicates that the vessel was smaller than 19 mm, which is the minimum allowable annulus size for a pvs size 21 (21 mm) perceval, and suggests that the valve was oversized.Over-sizing is warned against in the perceval ifu due to the possibility of stent folding resulting in regurgitation.Given this information, and our inability to replicate the reported folding event in a simulation, it was concluded that this event likely occurred due to mis-sizing, and was not valve related.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERCEVAL SUTURELESS AORTIC HEART VALVE
Type of Device
TISSUE HEART VALVE
Manufacturer (Section D)
LIVANOVA CANADA CORP.
5005 north fraser way
burnaby, bc
Manufacturer (Section G)
LIVANOVA CANADA CORP.
5005 fraser north way
burnaby, bc
Manufacturer Contact
francesca crovato
5005 fraser north way
burnaby, bc 
MDR Report Key6430328
MDR Text Key70734841
Report Number3004478276-2017-00038
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P150011
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 10/06/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/23/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Expiration Date05/08/2017
Device Model NumberPVS21
Device Catalogue NumberICV1208
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/20/2017
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/08/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured05/08/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age81 YR
Patient Weight60
-
-